Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.69 +0.01 (+0.98%)
At close: Nov 11, 2026 · 4:00 PM EST

Connect Biopharma Holdings (CNTB) EBIT Margin (2024 - 2026)

Updated

Connect Biopharma Holdings (CNTB) recorded EBIT Margin of -635.98% in Q2 2026, up 27330.68 percentage points from -27966.67% a year earlier and up 10965.79 percentage points from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) EBIT Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Connect Biopharma Holdings' EBIT Margin came in at -2384.49% as of Jun 30, 2026, up 75.36 percentage points year-over-year; for FY2025, it was -90740.63%, down 90654.38 percentage points from FY2024.

  • Across earlier years, EBIT Margin came in at -86.24% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Connect Biopharma Holdings 42.82 Mn -133.85 Mn - -635.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -635.98%
Mar 31, 2026 -11,601.78%
Sep 30, 2025 -110,481.25%
Jun 30, 2025 -27,966.67%
Dec 31, 2024 -1,378.08%
Sep 30, 2024 -1,135.85%
API Access

Connect Biopharma Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CNTB&period=max&api_key=YOUR_API_KEY